LCID
Lucid Group, Inc.
LCID has a slight edge over WKSP overall, supported by lower modeled downside.
WKSP
Worksport Ltd.
WKSP offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
WKSP Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
WKSP's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
WKSP PE Valuation
WKSP has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
WKSP Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| -- | |
| Limited | |
| High |
Analysts expect WKSP's losses to shrink, with revenue holding steady.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
WKSP has the stronger earnings trend. Trailing diluted EPS is down 224% for LCID versus WKSP down 127%.
WKSP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$6.50 | +$2.00 |
| Q2 2024 | -$7.40 | +$0.50 |
| Q1 2024 | -$8.10 | -$0.40 |
| Q4 2023 | -$8.40 | -$1.10 |
| Q3 2023 | -$8.50 | +$1.40 |
| Q2 2023 | -$7.90 | +$1.80 |
| Q1 2023 | -$7.70 | +$0.80 |
| Q4 2022 | -$7.30 | +$1.50 |
WKSP is still losing money, but far less than before: $1.78 per share over the past year, against $9.90 at its worst in late 2022.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID's revenue has grown year over year for 11 quarters in a row: $350M last quarter, up 4.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
WKSP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.2M | +44% |
| Q2 2026 | $5.2M | +27% |
| Q1 2026 | $3.3M | +48% |
| Q4 2025 | $4.7M | +62% |
| Q3 2025 | $5M | +61% |
| Q2 2025 | $4.1M | +114% |
| Q1 2025 | $2.2M | +337% |
| Q4 2024 | $2.9M | +249% |
WKSP has the edge over LCID on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -47% | +48 points |
| Q2 2026 | -73% | +15 points |
| Q1 2026 | -173% | +17 points |
| Q4 2025 | -129% | +7.7 points |
| Q3 2025 | -96% | +30 points |
| Q2 2025 | -88% | +115 points |
| Q1 2025 | -190% | +520 points |
| Q4 2024 | -137% | +286 points |
WKSP has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
WKSP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$399.9K | +$4.2M |
| Q2 2026 | -$3.5M | -$347.4K |
| Q1 2026 | -$8.3M | -$4.3M |
| Q4 2025 | -$6.3M | -$4.1M |
| Q3 2025 | -$4.6M | -$2.9M |
| Q2 2025 | -$3.2M | +$586K |
| Q1 2025 | -$4M | -$1M |
| Q4 2024 | -$2.2M | +$1.8M |
WKSP has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has the edge over WKSP on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
WKSP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +15% | +1.7M shares |
| 1 year | +157% | +8.3M shares |
| 3 years | +697% | +11.9M shares |
| 5 years | +4662% | +13.3M shares |
WKSP has 14M diluted shares, up 157% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
WKSP Net Leverage
WKSP's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
WKSP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 7.3 | Oversold |
WKSP's weekly RSI is 34 (neutral) and its Stochastic is 7 (oversold).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
WKSP PE vs Consumer Cyclical Sector
WKSP has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
WKSP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.36 | 2.8% below |
| 20 week MA | $0.53 | 34% below |
| 50 week MA | $1.09 | 68% below |
| 100 week MA | $2.75 | 87% below |
| 200 week MA | $8.50 | 96% below |
WKSP is in a downtrend: it's below all five of its weekly moving averages, and 96% below its 200-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has the edge over WKSP on returns for 2026, with the stronger performance.
WKSP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.8 | $25.6 | +100% |
| 2021 | $25.6 | $29.2 | +14% |
| 2022 | $29.2 | $12.0 | -59% |
| 2023 | $12.0 | $14.9 | +24% |
| 2024 | $14.9 | $9.20 | -38% |
| 2025 | $9.20 | $2.34 | -75% |
| 2026 YTD | $2.34 | $0.35 | -85% |
WKSP's yearly returns have swung widely, from +100% in 2020 to −75% in 2025. It's down 85% so far in 2026.